BU — Burcon NutraScience Balance Sheet
0.000.00%
- CA$28.80m
- CA$46.84m
- CA$0.38m
Annual balance sheet for Burcon NutraScience, fiscal year end - March 31st, CAD millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Short Term Investments | 14 | 7 | 1.46 | 4.2 | 7.28 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0.339 | 0.2 | 0.332 | 0.592 | 0.132 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 14.6 | 7.62 | 1.86 | 5.19 | 7.8 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 1.01 | 0.859 | 0.984 | 1.1 | 15.8 |
| Net Goodwill | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 37.7 | 29.3 | 9.9 | 12.9 | 30.7 |
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 1.45 | 1.04 | 0.625 | 1.35 | 4.29 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Liabilities | 1.45 | 1.1 | 5.76 | 7.76 | 23.7 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 36.3 | 28.2 | 4.14 | 5.15 | 6.94 |
| Total Liabilities & Shareholders' Equity | 37.7 | 29.3 | 9.9 | 12.9 | 30.7 |
| Total Common Shares Outstanding |